https://www.cataliocapital.com/portfolio/medra
Medra | Catalio Capital Portfolio
Medra is an early-stage technology company developing an AI-powered Continuous Science Platform that accelerates data generation and automates experimentation...
catalio capitalmedraportfolio
https://www.cataliocapital.com/portfolio/freenome
Freenome | Catalio Capital Portfolio
Freenome is developing a suite of blood-based, single-cancer screening tests for the purpose of detecting disease at its earliest and most treatable stages.
catalio capitalfreenomeportfolio
https://www.cataliocapital.com/portfolio/haystack-oncology
Haystack Oncology | Catalio Capital Portfolio
Haystack Oncology is a Catalio-initiated liquid biopsy diagnostic company developing a best-in-class assay for the detection of minimal residual disease (MRD)...
catalio capitalhaystackoncologyportfolio
https://www.cataliocapital.com/portfolio/thea-ai
Thea AI | Catalio Capital Portfolio
Thea is a consumer skincare platform that uses facial imaging, ingredient-level analysis, and a large multi-brand product database to deliver...
catalio capitaltheaaiportfolio
https://www.cataliocapital.com/portfolio/immunai
Immunai | Catalio Capital Portfolio
Immunai combines single cell profiling with artificial intelligence to identify the multi-omic signature of successful cancer immunotherapies and accelerate...
catalio capitalportfolio
https://www.cataliocapital.com/portfolio/insightec
Insightec | Catalio Capital Portfolio
Insightec is a global healthcare company creating the next generation of patient care by realizing the therapeutic power of acoustic energy.
catalio capitalportfolio
https://www.cataliocapital.com/
Catalio Capital Management
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or...
catalio capitalmanagement
https://www.cataliocapital.com/portfolio/compass
Compass Pathways | Catalio Capital Portfolio
COMPASS Pathways (NASDAQ: CMPS) is a mental healthcare company dedicated to accelerating patient access to evidence-based innovation in mental health, working...
catalio capitalcompasspathwaysportfolio
https://www.cataliocapital.com/portfolio/bayesian-health
Bayesian Health | Catalio Capital Portfolio
Bayesian Health is a digital health company that aims to improve patient outcomes by empowering clinicians with the data and insight they need to make the...
catalio capitalbayesianhealthportfolio
https://www.cataliocapital.com/portfolio/iambic
Iambic | Catalio Capital Portfolio
Iambic is an AI-enabled drug discovery company dramatically accelerating the development of best-in-class drugs.
catalio capitalportfolio
https://www.cataliocapital.com/portfolio/audicus
Audicus | Catalio Capital Portfolio
Audicus is a tele-audiology leader, improving access and affordability of hearing aids though online hearing tests and white-labeling of devices.
catalio capitalportfolio
https://www.cataliocapital.com/portfolio/thrive-sciences
Thrive Earlier Detection | Catalio Capital Portfolio
Thrive Earlier Detection is a cancer diagnostics company developing a liquid biopsy-based screening test to detect cancer in its earlier, pre-metastatic stages.
catalio capitalthriveearlierdetectionportfolio
https://www.cataliocapital.com/portfolio/noetik
Noetik | Catalio Capital Portfolio
Noetik is a machine learning enabled drug discovery company developing novel precision immune oncology assets.
catalio capitalportfolio
https://www.cataliocapital.com/portfolio/cagepharma
Cage Pharmaceuticals | Catalio Capital Portfolio
Cage Pharmaceuticals is a preclinical biopharmaceutical company focused on the development of compounds targeting tumor metabolism.
catalio capitalcagepharmaceuticalsportfolio
https://www.cataliocapital.com/portfolio/arrivent
ArriVent | Catalio Capital Portfolio
ArriVent is a clinical stage drug development company in-licensing mature, de-risked assets from Asia with first-in-class or best-in-class potential in the...
catalio capitalarriventportfolio
https://www.cataliocapital.com/portfolio/somethings
Somethings | Catalio Capital Portfolio
Somethings is a tech‑enabled youth mental health company delivering certified peer‑specialist support to adolescents.
catalio capitalportfolio
https://www.cataliocapital.com/portfolio/hippocratic-ai
Hippocratic AI | Catalio Capital Portfolio
Hippocratic AI is a healthtech company developing safety-focused generative AI voice agents that serve as digital nursing support staff for non-diagnostic,...
catalio capitalhippocraticaiportfolio
https://www.cataliocapital.com/portfolio/dna-script
DNA Script | Catalio Capital Portfolio
DNA Script is a commercial stage biotechnology company developing a benchtop DNA printer, putting synthesis capabilities in the hands of end users.
catalio capitaldnascriptportfolio
https://www.cataliocapital.com/portfolio/protara-therapeutics
Protara Therapeutics | Catalio Capital Portfolio
Protara is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases.
catalio capitaltherapeuticsportfolio
https://www.cataliocapital.com/portfolio/pillar-biosciences
Pillar Biosciences | Catalio Capital Portfolio
Pillar Biosciences is a molecular diagnostic company providing decentralized NGS testing solutions to enable highly accurate and accessible cancer care...
catalio capitalpillarbiosciencesportfolio
https://www.cataliocapital.com/portfolio/ensoma
Ensoma | Catalio Capital Portfolio
Ensoma is a pre-clinical stage biotechnology company developing in vivo genomic medicines for a variety of disease indications.
catalio capitalportfolio
https://www.cataliocapital.com/portfolio/pgdx
Personal Genome Diagnostics (PGDx) | Catalio Capital Portfolio
Personal Genome Diagnostics (PGDx) is an oncology company specializing in high-throughput next-generation sequencing and proprietary algorithms to identify...
catalio capitalpersonalgenomediagnosticsportfolio
https://www.cataliocapital.com/portfolio/clasp-therapeutics
Clasp Therapeutics | Catalio Capital Portfolio
Clasp Therapeutics is a Catalio-initiated venture that seeks to generate precision immunotherapies targeting the most common cancer-causing mutations.
catalio capitalclasptherapeuticsportfolio
https://www.cataliocapital.com/portfolio/octant-bio
Octant Bio | Catalio Capital Portfolio
Octant Bio is a drug discovery company combining high-throughput synthetic biology with in-depth biological profiling to address complex disease targets.
catalio capitaloctantbioportfolio